+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Psychopharmacology of Neurologic Disease, Vol 165. Handbook of Clinical Neurology

  • ID: 4753625
  • Book
  • December 2019
  • 458 Pages
  • Elsevier Science and Technology
1 of 2

Psychopharmacology of Neurologic Disease, Volume 165 in the Handbook of Clinical Neurology series, provides clinicians with an up-to-date, critical review of the best approaches to treatment of neurologic disease as discussed by experienced clinical investigators. The book is organized into sections on dementia, delirium, movement disorders, hereditary degenerative disease, epilepsy and psychogenic seizures, brain vascular disease, pseudobulbar affect, traumatic brain injury, neuro-oncology, multiple sclerosis and other demyelinating disorders, chronic fatigue syndrome/fibromyalgia, pain, headache, sleep disorders, autoimmune encephalitis/anti- NMDA encephalitis, functional sensory neurologic symptom disorders and neurodevelopmental disorders.

Each of these diagnostic categories has a significant incidence of behavioral symptomatology that is secondary to the neurologic diagnosis that can serve to complicate other therapeutic interventions, alter the course of illness, and cause distress in patients and family caregivers.

  • Provides a systematic, evidence-based compendium of best practices in the treatment of behavioral symptomatology relating to neurologic conditions
  • Integrates state-of-the-art approaches in treating all behavioral symptomatology across all major neurologic disorders
  • Explores psychopharmacological intervention, non-pharmacological strategies, behavioral symptomatology, and therapeutic interventions
Note: Product cover images may vary from those shown
2 of 2
1. Psychiatric manifestations of neurologic disease: Etiology, phenomenology and treatment
2. Behavioral and psychological symptoms in Alzheimer's dementia and vascular dementia
3. Frontotemporal dementia
4. Therapies for prion diseases
5. Behavioral symptomatology and psychopharmacology of Lewy Body dementia
6. Comorbid depression and apathy in HIV-associated neurocognitive disorders in the era of chronic HIV infection
7. Neuropsychiatric aspects of Parkinson disease psychopharmacology: insights from circuit dynamics
8. Tourette disorder and other tic disorders
9. Progressive supranuclear palsy, multiple system atrophy and corticobasal degeneration
10. The psychopharmacology of Huntington disease
11. The psychopharmacology of Wilson disease and other metabolic disorders
12. The psychopharmacology of epilepsy
13. The psychopharmacology of brain vascular disease/post-stroke depression
14. Pseudobulbar affect
15. Psychopharmacology of traumatic brain injury
16. The psychopharmacology of primary and metastatic brain tumors and paraneoplastic syndromes
17. Psychiatric manifestations and psychopharmacology of autoimmune encephalitis: A multidisciplinary approach
18. Psychopharmacology of multiple sclerosis
19. Psychopharmacology of chronic pain
20. Psychopharmacology of headache and its psychiatric comorbidities
21. Psychopharmacology of sleep disorders
22. Sensory neurologic symptom disorders
23. Psychopharmacology of neurobehavioral disorders
24. The psychopharmacology of autism spectrum disorder and Rett syndrome
25. The psychopharmacology of catatonia, neuroleptic malignant syndrome, akathisia, tardive dyskinesia, and dystonia
Note: Product cover images may vary from those shown